FRIDAY, Nov. 4, 2022 (HealthDay News) — The U.S. Food and Drug Administration has proposed limiting the amount of nicotine in cigarettes to minimally addictive levels, but there’s been concern that the drop in nicotine could exacerbate anxieties in smokers who might already battle mood issues. However, a new studyContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — While it isn’t possible to tell parents how long their child will need to remain in intensive care with a serious case of RSV, new research has unearthed clues that may make it easier to predict which kids will require a longer stay.Continue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — New drugs that could slow or prevent the start of dementia would be groundbreaking, but a new poll suggests many middle-aged adults may be reluctant to take part in the studies that test those medications. Only about 12% of the roughly 1,000 peopleContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) – Infant head-shaping pillows are not approved by the U.S. Food and Drug Administration and should not be used, the agency warned Thursday. The pillows can create an unsafe sleep environment for infants, potentially contributing to the risk of suffocation and death. Marketed asContinue Reading
Low-nicotine cigarettes won’t leave smokers agitated. Cigarettes with nicotine at 5% of the normal dose can help anxious or depressed smokers quit, without adding to the mood or anxiety problems that led them to smoke in the first place, a new study finds. Read more Nasal swab might gauge severityContinue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — A new study has shown the blood pressure drug telmisartan may offer new hope as an Alzheimer’s treatment in Black patients. It did not show the same benefit in white people. Learning how people from different ethnic groups respond to the same drugContinue Reading
THURSDAY, Nov. 3, 2022 (HealthDay News) — Monkeypox spreads even before a person shows any telltale lesions or other symptoms, a new study suggests. More than half of monkeypox transmission in the United Kingdom occurred in the pre-symptomatic phase, the researchers said. The new findings — published online Nov. 2Continue Reading
THURSDAY, Nov. 3, 2022 — U.S. doctors prescribing opioids for pain relief now have a new — and more nuanced — set of guidelines from the federal government. Issued by the U.S. Centers for Disease Control and Prevention on Thursday, the new recommendations incorporate new science developed since the lastContinue Reading
THURSDAY, Nov. 3, 2022 (HealthDay News) — Out of the more than 25,000 U.S. cases of monkeypox reviewed in a new study, just 0.3% occurred in people under the age of 18, new government data shows. Most of the kids and teens who contracted the virus — 89% — “wereContinue Reading
THURSDAY, Nov. 3, 2022 (HealthDay News) — A single psychedelic trip with psilocybin — the mind-altering component of magic mushrooms — appears to lift the fog of major depression in some hard-to-treat patients, a new clinical trial reports. A 25-milligram dose of a synthetic psilocybin compound called COMP360 caused aContinue Reading